US Stocks
/
Allogene Therapeutics, Inc. Share Price
Allogene Therapeutics, Inc. Share Price

Allogene Therapeutics, Inc. Share Price

NASDAQ: ALLO | Small Cap
$1.46
+$0.06 (4.30%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Allogene Therapeutics, Inc. Stock Performance

Open
$1.39
Prev. Close
$1.40
Circuit Range
N/A
Day Range
$1.38 - $1.48
Year Range
$1.04 - $4.45
Volume
3,24,511
Average Traded
$1.43

Allogene Therapeutics, Inc. Share Price Today

As of 11 October 2026, Allogene Therapeutics, Inc.'s share price is $1.46. The stock opened at $1.39, compared to its previous close of $1.40. During today's trading session, Allogene Therapeutics, Inc.'s share price traded between $1.38 and $1.48, with an average price of $1.43. Over the past 52 weeks, the stock has recorded a high of $4.45 and a low of $1.04. In terms of performance, Allogene Therapeutics, Inc.'s share price has declined by 31.53% over the last six months and is up 17.81% on a year-on-year basis.

Allogene Therapeutics, Inc. Share Price Chart

$1.38$1.48
L
Show Current Price
H

Allogene Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$321.01M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-37.94%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-3.09%

Allogene Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$4.64
Net Profit-$41.40-$38.81-$42.61-$42.68
Net Profit MarginN/AN/AN/A-919.83%
Income ChangeN/A6.26%-9.79%-0.16%

Allogene Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.16$0.10$0.02$0.00
Net Profit-$340.41-$327.27-$257.59-$190.89
Net Profit Margin-212756.25%-327270.00%-1287950.00%N/A
Income ChangeN/A3.86%21.29%25.89%

About Allogene Therapeutics, Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Allogene Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.59
$1.46
-8.20%
Sep 2026
$1.99
$1.58
-24.34%
Aug 2026
$1.87
$2.10
+12.03%
Jul 2026
$2.05
$1.87
-9.88%
Jun 2026
$2.18
$2.08
-5.03%
May 2026
$2.09
$2.19
+2.82%
Apr 2026
$2.50
$2.13
-12.91%
Mar 2026
$2.67
$2.44
-12.54%
Feb 2026
$1.80
$2.79
+51.63%
Jan 2026
$1.35
$1.84
+34.80%
Dec 2025
$1.45
$1.36
-5.86%
Nov 2025
$1.26
$1.45
+17.41%

ALLO Share Price FAQs

What is Allogene Therapeutics, Inc. share price today?

chevron-up
Allogene Therapeutics, Inc. share price today is $1.46 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Allogene Therapeutics, Inc. stock?

chevron-up
The 52 week high of Allogene Therapeutics, Inc. stock is $4.45, while the 52 week low is $1.04 as of 10 Oct '26.

What is ALLO's market capitalisation today?

chevron-up
ALLO market capitalisation is $321.01M as of October 11, 2026, at 4:01 pm IST.

What is ALLO's net income for the last quarter?

chevron-up
ALLO's net income for the last quarter is -42.68B USD.

What is the 5 year returns of ALLO?

chevron-up
The 5 year returns of ALLO is -91.56% as on 10 Oct '26.

What is the high & low stock price of ALLO today?

chevron-up
ALLO stock price hit a high of $1.48 and low of $1.38 as of 10 Oct '26.

Can I buy ALLO shares in India?

chevron-up
Yes. You can buy ALLO in India by opening an international trading account.